Real-World Application for Innovation and Development
ID: FDA-SSN-75F40125Q00029Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

NAICS

Computer Systems Design Services (541512)

PSC

IT AND TELECOM - HIGH PERFORMANCE COMPUTING (HPC) SUPPORT SERVICES (LABOR) (DB01)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/92aaebdd080e4f7595b932e0a6004816/view
Timeline
  1. 1
    Posted Jan 21, 2025, 12:00 AM UTC
  2. 2
    Updated Jan 21, 2025, 12:00 AM UTC
  3. 3
    Due Feb 11, 2025, 5:00 PM UTC
Description

The U.S. Food and Drug Administration (FDA) is seeking qualified small businesses to support its Real-World Application for Innovation and Development (RAPID) program, which aims to enhance regulatory processes through advanced data analytics and artificial intelligence. The primary objectives include the development and deployment of innovative prototypes, system maintenance, and the integration of advanced analytics into the regulatory framework to improve drug safety evaluations and regulatory reviews. This initiative is crucial for enabling FDA reviewers to efficiently access real-time data and analytics, particularly during public health events. Interested vendors must submit a capability statement by February 11, 2025, detailing their qualifications in relevant areas such as AI and cloud technologies, and can contact Noah Padilla at Noah.Padilla@fda.hhs.gov for further information.

Point(s) of Contact
Noah Padilla
Noah.Padilla@fda.hhs.gov
Files
Title
Posted
FDA-SSN-75F40125Q00029_RAPID VI_Instructions.pdf
Jan 21, 2025, 8:04 PM UTC
The U.S. Food and Drug Administration (FDA) has issued a Sources Sought Notice to gather market research on potential services for its Real-World Application for Innovation and Development (RAPID) platform. This initiative, under the Center for Drug Evaluation and Research, aims to enhance the existing AWS platform and develop innovative applications and prototypes to modernize the regulatory review process. The FDA seeks to identify small businesses eligible under GSA MAS Schedules 54151S (IT Professional Services) and 54151HEAL (Health IT Services) that can support various objectives, including system maintenance, upgrades, and innovative AI and cloud technologies. The RAPID platform is integral to enabling FDA reviewers to access real-time data and analytics to inform regulatory decisions efficiently, especially during public health events. Interested vendors are requested to submit a capability statement detailing their qualifications and previous experiences in relevant areas such as AI, data integration, and cloud deployment, by February 11, 2025. This notice does not commit the government to any award and emphasizes voluntary participation from interested parties.
FDA-SSN-75F40125Q00029_RAPID VI_SOW Draft.pdf
Jan 21, 2025, 8:04 PM UTC
The U.S. Food and Drug Administration (FDA) is soliciting proposals for the Real-World Application for Innovation and Development (RAPID) program, aimed at advancing innovative regulatory processes through enhanced data analytics and artificial intelligence. The RAPID platform is designed to support FDA operations by improving the efficiency and effectiveness of drug safety evaluations and regulatory reviews via cloud-based technologies and data analysis tools. The primary objectives include developing and deploying prototypes that fulfill mission-critical needs, maintaining existing systems, and integrating advanced analytics into the regulatory framework. Important tasks for contractors encompass project management, research, and continued innovation while adhering to strict compliance with security protocols, organizational conflict of interest considerations, and accessibility standards under Section 508. The contract structure features a base period of one year with four option years, focusing on project governance, database administration, and collaborative development. Contractors must adhere to comprehensive reporting requirements and are responsible for the transition of services as necessary. Overall, this initiative reflects the FDA's commitment to leverage cutting-edge technology to enhance public health oversight and regulatory capacity.
Lifecycle
Title
Type
Real-World Application for Innovation and Development
Currently viewing
Sources Sought
Similar Opportunities
Drug Utilization: Hospital Inpatient & Emergency Dept. Data (Recompete)
Buyer not available
The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for a contract titled "Drug Utilization: Hospital Inpatient & Emergency Dept. Data (Recompete)." The primary objective of this procurement is to gain immediate and unlimited access to commercially available drug utilization data for both adult and pediatric populations in hospitals, which will support the FDA's regulatory activities related to drug safety and utilization assessments. This data is crucial for enhancing public health safety and informing regulatory decision-making regarding marketed drugs. Interested parties should note that the contract may cover up to $5 million over several years, with a response deadline of April 16, 2025. For further inquiries, potential offerors can contact Ryan Alexander at ryan.alexander@fda.hhs.gov.
PRIMO Software Licensing
Buyer not available
The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.
Food and Drug Administration (FDA) Regulatory Compliance Training
Buyer not available
The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking proposals for FDA Regulatory Compliance Training aimed at enhancing the competency of personnel involved in FDA-regulated research activities. The training will cover essential areas such as Good Clinical Practices (GCP), Good Laboratory Practices (GLP), current Good Manufacturing Practices (cGMP), and Quality Systems Regulations (QSR), ensuring compliance with federal and Department of Defense regulations. This initiative is critical for the U.S. Army Medical Research and Development Command (USAMRDC) as it supports the development of FDA-approved pharmaceuticals and devices for military personnel. Interested contractors should contact Matthew Gembe at matthew.w.gembe.civ@health.mil or 301-619-1350 for further details, with proposals due in alignment with the specified timelines in the solicitation documents.
R408--FRAUD PREVENTION SERVICES
Buyer not available
The Department of Veterans Affairs (VA) is seeking information through a Request for Information (RFI) for Fraud Prevention Services (FPS) aimed at safeguarding veteran benefits and promoting fiscal responsibility. The initiative, led by the Office of Financial Management's Benefits Delivery Protection & Remediation (BDP&R) Directorate, focuses on collaborating with industry experts to develop innovative strategies utilizing advanced technologies, including artificial intelligence and machine learning, to combat fraud, waste, and abuse (FWA) affecting veteran services. Interested vendors are invited to submit their company information, capability statements, and responses to specific questions by May 19, 2025, with a virtual Industry Day scheduled for June 3, 2025, to discuss the RFI in detail. For further inquiries, vendors can contact Gregory Stevens at gregory.stevens@va.gov or by phone at 313-354-2194.
DLA Emergent IV Research and Development Program
Buyer not available
The Defense Logistics Agency (DLA) is seeking proposals for the Emergent IV Research and Development Program, a Broad Agency Announcement (BAA) aimed at advancing innovative research in various areas of interest, including medical logistics, advanced manufacturing, and artificial intelligence applications. The program invites interested parties to submit "White Papers" that outline specific projects related to the identified areas, with the potential for selected submissions to lead to requests for full technical and cost proposals. This initiative is crucial for enhancing the DLA's logistics capabilities and operational efficiency, with a total funding ceiling of $125 million over a five-year period. Interested vendors can reach out to the DLA's R&D Mailbox at RandD.DCSO@dla.mil for further inquiries, and must adhere to the established submission timelines, with key deadlines for White Papers set for April 19 and April 26, 2024.
RFI Records Management App Using AI
Buyer not available
The Department of the Treasury, Bureau of the Fiscal Service, is seeking information from vendors capable of providing Commercial-Off-The-Shelf (COTS) records management applications that utilize artificial intelligence (AI) technology. The objective is to enhance the efficiency of managing records throughout their lifecycle, including identification, categorization, retention, and destruction, while migrating existing records from the current system, Open Text Content Manager. This initiative aims to reduce reliance on human intervention and improve accuracy in records management processes. Interested vendors must submit their responses by email to purchasing@fiscal.treasury.gov no later than 10:00 a.m. on April 22, 2025, and are encouraged to include a high-level capabilities statement along with relevant business and technical information.
Request for Information for Structured Product Labeling (SPL) Document Support for DHA R&D - MRDC - ORA
Buyer not available
The Defense Health Agency (DHA) is seeking information through a Request for Information (RFI) regarding Structured Product Labeling (SPL) document support for its Research & Development Medical Research and Development Command (MRDC). The objective is to assess the feasibility of acquiring commercial solutions that facilitate the submission of SPL documents to the FDA for three licensed New Drug Application (NDA) products requiring labeling changes. This initiative is crucial for ensuring compliance with FDA regulations and maintaining the accuracy of product labeling, which is vital for public health and safety. Interested parties must submit their Capabilities Statements by April 17, 2025, detailing their ability to create, update, and submit SPL documents, along with adherence to technical standards and system validation processes. For further inquiries, respondents can contact Alana M. Sowers at alana.m.sowers.civ@health.mil.
Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.